Evidence map›Paper›PMID 28378549›Full record

ArticleJournal of Korean medical science2017

Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.

Tae Yon Sung, Yun Mi Choi, Won Gu Kim, Yu Mi Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Dong Eun Song

Abstract read
In one paragraph

Article in Journal of Korean medical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tae Yon SungDepartment of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.ORCID http://orcid.org/0000-0002-2179-6269
Yun Mi ChoiDepartment of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.ORCID http://orcid.org/0000-0001-8209-874X
Won Gu KimDepartment of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.ORCID http://orcid.org/0000-0002-8404-7759
Yu Mi LeeDepartment of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.ORCID http://orcid.org/0000-0002-8183-2604
Tae Yong KimDepartment of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.ORCID http://orcid.org/0000-0003-4982-4441
Young Kee ShongDepartment of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.ORCID http://orcid.org/0000-0002-7911-9471
Won Bae KimDepartment of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.ORCID http://orcid.org/0000-0003-4544-1750
Dong Eun SongDepartment of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. hipuha@hanmail.net.ORCID http://orcid.org/0000-0002-9583-9794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to describe rare variants of adrenocortical carcinoma (ACC) and to compare the prognosis with that of conventional ACC. We retrospectively reviewed 8 cases of myxoid variant, 1 sarcomatoid variant, and 14 cases of conventional ACC, who underwent surgical resection at the Asan Medical Center between 1996 and 2014. An analysis of the clinicopathological characteristics, including the Weiss score, Ki-67 labeling index, and reticulin framework assessment is presented. The mean age of patients with myxoid/sarcomatoid ACC was 45 years; 4 out of 9 patients were women. Mean primary tumor size was 12.9 cm and the mean weight was 702.4 g. Seven patients presented in an advanced stage (stage III/IV); 8 of these eventually developed distant metastasis. The mean Weiss score was 5.0 points and the Ki-67 labeling index was 15.6%. The extent of myxoid or sarcomatoid change on histological examination ranged from 10% to 75% of the examined tumor areas; reticulin framework alteration was observed in all cases. Four patients showed venous tumor thrombus. Most of the clinicopathological parameters were not significantly different from those of conventional ACC. However, myxoid or sarcomatoid variant (hazard ratios [HR], 3.59; 95% confidence intervals [CI], 1.13-11.38; P = 0.030) and Ki-67 labeling index (HR, 3.97; 95% CI, 1.18-13.41; P = 0.030) were independent predictors of overall survival after adjusting for age and sex. Myxoid or sarcomatoid histological features or an increased Ki-67 labeling index may be associated with poor overall survival in patients with ACC.

Indexed as

Adrenal Cortex NeoplasmsAdrenocortical CarcinomaAdultFemaleHumansImmunohistochemistryKi-67 AntigenMaleMiddle AgedNeoplasm MetastasisNeoplasm StagingPrognosisProportional Hazards ModelsRetrospective StudiesSarcomaSurvival RateKi-67 AntigenAdrenocortical CarcinomaKi-67MyxoidSarcomatoidSurvival

Identifiers

PMID28378549
PMCPMC5383608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.